Centre National De La Recherche Scientifique Cnrs

USPTO Trademark & Patent Filings

Trademark applications and grants for Centre National De La Recherche Scientifique Cnrs. Centre National De La Recherche Scientifique Cnrs has 7 trademark applications. The latest application filed is for "STELLA SYSTEME DE TRAITEMENT POUR L'EXPLOITATION EN LIGNE DE LA LANGUE"

Company Profile

Centre National de la Recherche Scientifique (CNRS)
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS
cnrs scientifique recherche la de national centre
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS - PARIS Cedex 16 FR
Centre National de la Recherche Scientifique (CNRS) - Paris FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) - PARIS FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) - Paris N/A FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) - CNRS
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE--CNRS - Paris N/A FR

Trademarks Patents

Patent Applications

Patent Application	Date
Temperature-controlled radio-frequency resonator and corresponding radio-frequency oscillator 20220311384 - 17/620829 Baron; Thomas ; et al.	2022-09-29
A NEUROPILIN ANTAGONIST IN COMBINATION WITH A P38ALPHA-KINASE INHIBITOR FOR THE TREATMENT OF CANCER 20220307021 - 17/614437 LEPELLETIER; Yves ; et al.	2022-09-29
LIPOPEPTIDE COMPOUNDS FOR THE TREATMENT OF PAIN DISORDERS 20220304965 - 17/721421 CENAC; Nicolas ; et al.	2022-09-29
NANO-RHEOLOGICAL BIOMARKERS FOR EARLY AND IMPROVED FOLLOW-UP OF PATHOLOGIES ASSOCIATED TO RBC DEFORMABILITY ALTERATION 20220299533 - 17/618731 ABOU; Berengere ; et al.	2022-09-22
RNA-BASED THERAPEUTIC METHODS TO PROTECT ANIMALS AGAINST PATHOGENIC BACTERIA AND / OR PROMOTE BENEFICIAL EFFECTS OF SYMBIOTIC AND COMMENSAL BACTERIA 20220288230 - 17/636225 NAVARRO; Lionel ; et al.	2022-09-15
Adaptive optics image acquisition method 11,451,722 - 17/277,462 Darson , et al. September 20, 2	2022-09-20
Reconfigurable antenna assembly having a metasurface of metasurfaces 11,444,386 - 17/055,315 Tripon-Canseliet , et al. September 13, 2	2022-09-13
BYL719 (alpelisib) for use in the treatment of PIK3CA-related overgrowth spectrum (pros-CLOVES syndrome) 11,433,059 - 15/998,950 Canaud September 6, 2	2022-09-06
BYL719 (alpelisib) for use in the treatment of PIK3CA-related overgrowth spectrum (pros-CLOVES syndrome) 11,433,059 - 15/998,950 Canaud September 6, 2	2022-09-06
Neuronal viability factor and use thereof in Alzheimer's disease 11,428,698 - 16/711,492 Leveillard , et al. August 30, 2	2022-08-30

Patent Grants & Applications

Trademark Applications

Mark Image Registration \| Serial	Trademark Application Date
"STELLA SYSTEME DE TRAITEMENT POUR L'EXPLOITATION EN LIGNE DE LA LANGUE" 79007903	STELLA SYSTEME DE TRAITEMENT POUR L'EXPLOITATION EN LIGNE DE LA LANGUE 2004-09-20
"TRÃSOR DE LA LANGUE FRANÃAISE" 3189549 79007901	TRÃSOR DE LA LANGUE FRANÃAISE 2004-09-20
"FRANTEXT" 3145661 79007902	FRANTEXT 2004-09-20
"OPENMASK" 3023891 79004757	OPENMASK 2004-01-29
"PASCAL BIOMED" 2634012 76060346	PASCAL BIOMED 2000-05-31
"MULTISCRIPT" 1444939 73602436	MULTISCRIPT 1986-06-05
"FLUX" 1338462 73419067	FLUX 1983-03-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.